Literature DB >> 20422157

A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects.

Benjamin D Hunt1, Leong L Ng, David G Lambert.   

Abstract

Urotensin-II (U-II) is an 11-amino acid cyclic peptide which exerts its actions through a G(q) protein-coupled receptor, UT. Much of the research focus of U-II is as a peptide of the periphery, particularly cardiovascular. Despite this, U-II was originally identified as a neuropeptide, and its expression is broad throughout the central nervous system. This brief review article catalogs the known sites of expression of UT within the CNS in the form of a diagrammatic rat brain atlas. Furthermore, the functional consequences of UT activation within specific brain regions are discussed along with the likely actions of synthetic UT ligands. Areas of high, medium, and low expression include the arcuate, paraventricular, and pedunculopontine tegmental nuclei, respectively. In the arcuate and paraventricular nuclei, where expression is high and moderate, U-II produces a pressor/tachycardic response in the former and a weaker response in the latter. Based on the known pharmacology of UT ligands (and assuming density is the primary determinant of efficacy in this case), we predict a weak response in the arcuate nucleus and possible antagonism of endogenous U-II response in the paraventricular nucleus by a low-efficacy partial agonist. These predicted responses lend themselves to relatively simple experimental verification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422157     DOI: 10.1007/s00210-010-0503-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

Review 1.  Urotensin II, a novel peptide in central and peripheral cardiovascular control.

Authors:  Anna M D Watson; Clive N May
Journal:  Peptides       Date:  2004-10       Impact factor: 3.750

2.  Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes.

Authors:  Hélène Castel; Mickaël Diallo; David Chatenet; Jérôme Leprince; Laurence Desrues; Marie-Thérèse Schouft; Marc Fontaine; Christophe Dubessy; Isabelle Lihrmann; Elisabeth Scalbert; Maria Malagon; Hubert Vaudry; Marie-Christine Tonon; Pierrick Gandolfo
Journal:  J Neurochem       Date:  2006-08-29       Impact factor: 5.372

3.  Localization of the urotensin II receptor in the rat central nervous system.

Authors:  Sylvie Jégou; Dorthe Cartier; Christophe Dubessy; Bruno J Gonzalez; David Chatenet; Hervé Tostivint; Elizabeth Scalbert; Jérome LePrince; Hubert Vaudry; Isabelle Lihrmann
Journal:  J Comp Neurol       Date:  2006-03-01       Impact factor: 3.215

4.  Urotensin-II receptor ligands. From agonist to antagonist activity.

Authors:  Paolo Grieco; Alfonso Carotenuto; Pietro Campiglia; Luciana Marinelli; Teresa Lama; Riccardo Patacchini; Paolo Santicioli; Carlo A Maggi; Paolo Rovero; Ettore Novellino
Journal:  J Med Chem       Date:  2005-11-17       Impact factor: 7.446

5.  In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803).

Authors:  Valeria Camarda; Martina Spagnol; Wei Song; Raffaella Vergura; Adelheid L Roth; Jonathan P Thompson; David J Rowbotham; Remo Guerrini; Erika Marzola; Severo Salvadori; Paolo Cavanni; Domenico Regoli; Stephen A Douglas; David G Lambert; Girolamo Calò
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

6.  Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.

Authors:  J J Maguire; R E Kuc; A P Davenport
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Urotensin II evokes neurotransmitter release from rat cerebrocortical slices.

Authors:  Tomoko Ono; Yoko Kawaguchi; Mihoko Kudo; Tetsuya Kushikata; Eiji Hashiba; Hitoshi Yoshida; Tsuyoshi Kudo; Kenichi Furukawa; Stephen A Douglas; Remo Guerrini; Girolamo Calo'; Kazuyoshi Hirota
Journal:  Neurosci Lett       Date:  2008-06-21       Impact factor: 3.046

8.  The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.

Authors:  David J Behm; Gerald Stankus; Christopher P A Doe; Robert N Willette; Henry M Sarau; James J Foley; Dulcie B Schmidt; Parvathi Nuthulaganti; James A Fornwald; Robert S Ames; David G Lambert; Girolamo Calo'; Valeria Camarda; Nambi V Aiyar; Stephen A Douglas
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

9.  Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.

Authors:  Christophe Dubessy; Dorthe Cartier; Benoît Lectez; Christine Bucharles; Nicolas Chartrel; Maïté Montero-Hadjadje; Patrice Bizet; David Chatenet; Hervé Tostivint; Elizabeth Scalbert; Jérome Leprince; Hubert Vaudry; Sylvie Jégou; Isabelle Lihrmann
Journal:  J Neurochem       Date:  2008-08-14       Impact factor: 5.372

10.  Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

Authors:  D Pearson; J E Shively; B R Clark; I I Geschwind; M Barkley; R S Nishioka; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  5 in total

1.  In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligands.

Authors:  Benjamin D Hunt; Leong L Ng; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06       Impact factor: 3.000

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus.

Authors:  Gabriela Cristina Brailoiu; Elena Deliu; Joseph E Rabinowitz; Douglas G Tilley; Walter J Koch; Eugen Brailoiu
Journal:  J Neurochem       Date:  2014-03-06       Impact factor: 5.372

4.  Urotensin II in invertebrates: from structure to function in Aplysia californica.

Authors:  Elena V Romanova; Kosei Sasaki; Vera Alexeeva; Ferdinand S Vilim; Jian Jing; Timothy A Richmond; Klaudiusz R Weiss; Jonathan V Sweedler
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

5.  Urotensin-related gene transcripts mark developmental emergence of the male forebrain vocal control system in songbirds.

Authors:  Zachary W Bell; Peter Lovell; Claudio V Mello; Ping K Yip; Julia M George; David F Clayton
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.